Sept 22 (Reuters) – Zealand Pharma A/S: * INITIATES GLOBAL PHASE 3 ZUPREME PROGRAM FOR PETRELINTIDE * PHASE 3A ZUPREME PROGRAM CONSISTS OF THREE TRIALS FOR PETRELINTIDE MONOTHERAPY * PRIMARY ENDPOINT
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Karen Brettell NEW YORK, Sept 22 (Reuters) - The tech-heavy Nasdaq hit an intraday record…
* Deal signed at UN General Assembly in New York * Agreement could end standoff…
By Elizabeth Howcroft PARIS, Sept 22 (Reuters) - Using AI agents for online shopping could…
MOSCOW, Sept 22 (Reuters) - Russian forces struck a cargo vessel in Ukraine's Black Sea…
VIDEO SHOWS: HIGHLIGHTS FROM THE ASIA GAMES WITH CHINA WINNING SETTING A NEW WORLD RECORD…
By Jason Lange WASHINGTON, Sept 22 (Reuters) - Three-quarters of Americans, some 73%, worry that…